The investment is aimed at making the subsidiary, a hub for Europe and Commonwealth of Independent States countries. The investment is mainly for improving the manufacturing capabilities of its subsidiaries manufacturing plant in Romania, restructuring the company and improving research and development capabilities. Ranbaxy Laboratories Limited, India’s largest pharmaceutical company, acquired Terapia SA for $324 million (Rs 13.47 billion) in June, 2006. Shares of the company closed at Rs 343.20, up Rs 2.15 or 0.63%. The total volume of share traded was 110,516 at the BSE (Friday). (myiris.com)